Human immunodeficiency virus and fungal infections

被引:2
|
作者
Guarner, Jeannette [1 ]
机构
[1] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
HIV; Fungi; Hyphae; Yeasts; Cryptococcus; Pneumocystis; REAL-TIME PCR; INVASIVE CANDIDIASIS; CLINICAL-ASPECTS; UNITED-STATES; DIAGNOSIS; EPIDEMIOLOGY; DERMATOPHYTOSIS; SPOROTRICHOSIS; HISTOPLASMOSIS; PATHOGENESIS;
D O I
10.10531/j.semdp.2017.04.007
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The discovery of HIV was largely due to the presence of Pneumocystis pneumonia (PCP) in young patients that did not have the usual known causes of immune deficiencies in the early 1980s. Currently, treatment with highly active anti-retroviral therapy (HAART) and the use of prophylaxis for PCP have lowered the frequency of fungal infections; however, these infections continue to cause morbidity and mortality in those patients that fall out or are not in care. The frequency of specific fungal diseases in HIV patients will depend on the prevalence of fungi in the particular geographic location. Nowadays, superficial and invasive Candida infections, PCP, and cryptococci are the most frequent fungal infections seen in HIV positive patients worldwide. The role of pathology in diagnosing fungal infections is crucial because a lesion may be biopsied without obtaining mycology cultures, certain organisms may take several weeks to grow, or the sample sent to the mycology laboratory may not have the organism. Following we will describe fungal infections that are particularly frequent in HIV infected patients and their key pathological features. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 50 条
  • [21] TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTIONS
    HIRSCH, MS
    KAPLAN, JC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (06) : 839 - 843
  • [22] Voiding dysfunction in human immunodeficiency virus infections
    Kane, CJ
    Bolton, DM
    Connolly, JA
    Tanagho, EA
    JOURNAL OF UROLOGY, 1996, 155 (02): : 523 - 526
  • [23] Viral infections in human immunodeficiency virus disease
    Cavert, W
    MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (02) : 411 - +
  • [24] TREATMENT OF INFECTIONS ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS
    GLATT, AE
    CHIRGWIN, K
    LANDESMAN, SH
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22): : 1439 - 1448
  • [25] Treatment of human immunodeficiency virus and hepatitis B virus infections
    Zoulim, F.
    Bailly, F.
    Johnson, M.
    Kessler, C.
    HAEMOPHILIA, 2012, 18 : 34 - 37
  • [26] Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections
    Overbaugh, J
    Luciw, PA
    Hoover, EA
    AIDS, 1997, 11 : S47 - S54
  • [27] Association of infections with human immunodeficiency virus and human papillomavirus in Honduras
    Ferrera, A
    Melchers, WJG
    Velema, JP
    Figueroa, M
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 57 (02): : 138 - 141
  • [28] Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections
    Cole, KS
    Murphey-Corb, M
    Narayan, O
    Joag, SV
    Shaw, GM
    Montelaro, RC
    JOURNAL OF VIROLOGY, 1998, 72 (10) : 7852 - 7859
  • [29] Surgical site infections in patients with human immunodeficiency virus
    Petrosillo, N
    Pan, A
    Puro, V
    ARCHIVES OF SURGERY, 2006, 141 (06) : 611 - 612
  • [30] Prophylaxis for opportunistic infections in patients with human immunodeficiency virus
    Katlama, C
    Jouan, M
    MEDECINE ET MALADIES INFECTIEUSES, 1996, 26 (8-9): : 742 - 751